Table 1 Incidence of hypertrophic cardiomyopathy.

From: Prevalence, incidence and mortality of hypertrophic cardiomyopathy based on a population cohort of 21.9 million in China

 

Newly diagnosed HCM cases

Population

Incidence (95% CI)

Per 100 000 person-years

Total

2010

1343

19,612,368

6.85 (6.48, 7.21)

2011

1320

20,231,159

6.52 (6.17, 6.88)

2012

1368

20,767,977

6.59 (6.24, 6.94)

2013

1344

21,246,815

6.33 (5.99, 6.66)

2014

1479

21,703,661

6.81 (6.47, 7.16)

2015

1659

21,875,603

7.58 (7.22, 7.95)

2016

1829

21,957,104

8.33 (7.95, 8.71)

2017

1989

21,947,103

9.06 (8.66, 9.46)

2018

2179

21,920,099

9.94 (9.52, 10.36)

2019

2575

21,904,097

11.76 (11.3, 12.21)

Males

2010

824

10,126,430

8.14 (7.58, 8.69)

2011

841

10,318,297

8.15 (7.60, 8.70)

2012

875

10,733,216

8.15 (7.61, 8.69)

2013

833

10,975,131

7.59 (7.07, 8.11)

2014

912

11,184,057

8.15 (7.63, 8.68)

2015

994

11,258,031

8.83 (8.28, 9.38)

2016

1203

11,262,398

10.68 (10.08, 11.29)

2017

1273

11,240,396

11.33 (10.7, 11.95)

2018

1396

11,223,394

12.44 (11.79, 13.09)

2019

1629

11,206,391

14.54 (13.83, 15.24)

Females

2010

519

9,483,938

5.47 (5.00, 5.94)

2011

479

9,912,861

4.83 (4.40, 5.26)

2012

493

10,034,761

4.91 (4.48, 5.35)

2013

511

10,271,684

4.97 (4.54, 5.41)

2014

567

10,519,604

5.39 (4.95, 5.83)

2015

665

10,617,573

6.26 (5.79, 6.74)

2016

626

10,694,705

5.85 (5.39, 6.31)

2017

716

10,706,706

6.69 (6.20, 7.18)

2018

783

10,696,705

7.32 (6.81, 7.83)

2019

946

10,697,705

8.84 (8.28, 9.41)

  1. HCM hypertrophic myocardiopathy.